Your session is about to expire
← Back to Search
Robotics
Robotic Brace Incorporating Electromyography (EMG) for Moderate Affected Arm Impairment After Stroke
Phase 1 & 2
Waitlist Available
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up twice before intervention; once after intervention; 2 months after intervention.
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a robotic arm brace for stroke survivors with weak arms. The brace detects muscle signals and helps move the arm, aiming to improve strength and coordination better than traditional therapy. The Armeo Spring exoskeleton robot has been used in previous studies to assist with arm rehabilitation in stroke patients.
Eligible Conditions
- Stroke
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ twice before intervention; once after intervention; 2 months after intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~twice before intervention; once after intervention; 2 months after intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline to after intervention and 3 months after intervention in the amount of active movement at each joint of the affected arm. This will be measured using the upper extremity section of the Fugl-Meyer Assessment.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Myomo + RTPExperimental Treatment1 Intervention
This group will be administered a regimen comprised of repetitive task specific practice (RTP) in conjunction with use of the robotic brace described elsewhere in this record.
Group II: MyomoActive Control1 Intervention
Patients in this group will only be administered the robotic brace described elsewhere in this record.
Group III: RTP onlyActive Control1 Intervention
Patients in this group will be administered repetitive task specific practice (RTP), emphasizing use of their affected arms during performance of valued, functional tasks.
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
438 Previous Clinical Trials
638,658 Total Patients Enrolled
31 Trials studying Stroke
14,768 Patients Enrolled for Stroke